Literature DB >> 19967411

The role of occupational upper extremity use in breast cancer related upper extremity lymphedema.

Gulgun Tahan1, Ronald Johnson, Lisa Mager, Atilla Soran.   

Abstract

BACKGROUND: Upper extremity (UE) use has been related to breast cancer-related lymph edema (BCRL). Our aim was to evaluate severity of BCRL in different occupation groups, according to upper extremity use.
METHODS: Fifty-five women with BCRL were recruited. Group-1 (n = 21), with a mean age of 59, included patients who worked continuously <30 min at a time and <or=8 h per day. Group-2 (n = 15), with a mean age of 54, were patients who worked continuously between 30 to 60 min at a time, and <or=8 h per day. Group-3 (n = 19), who had a mean age of 51, included patients who were working continuously for >1 h and >8 h per day.
RESULTS: The age, operation type, infection occurrence, radiotherapy status, and the operation on the side of the dominant hand were not statistically different between the groups. The stage and grade of the BCRL in group-3 were higher than the other groups (both p < 0.001). The restriction of shoulder movements on the operation side (p = 0.04) and shoulder physiotherapy need (p < 0.001) were the highest in group-3. Arm pain (p = 0.004) and pain medicine needs (p = 0.028) in group-1 were lower than the other groups.
CONCLUSION: Group-3 had the worst BCRL clinical stage and grade status and other breast cancer treatment related morbities. Occupations that require greater use of the upper extremities. At present there is a need for closer monitoring of patients with more severe BCRL. Potential exacerbating and maintaining factors of functional limitations and pain need to considered so that clinical management addresses these in relation to daily use of the affected UE.

Entities:  

Mesh:

Year:  2009        PMID: 19967411     DOI: 10.1007/s11764-009-0103-4

Source DB:  PubMed          Journal:  J Cancer Surviv        ISSN: 1932-2259            Impact factor:   4.442


  23 in total

Review 1.  Arm edema in breast cancer patients.

Authors:  V S Erickson; M L Pearson; P A Ganz; J Adams; K L Kahn
Journal:  J Natl Cancer Inst       Date:  2001-01-17       Impact factor: 13.506

2.  Influence of some anthropometric parameters on the risk of development of distal complications after mastectomy carried out because of breast carcinoma.

Authors:  Zbigniew Kopanski; Tomasz Wojewoda; Aleksandra Wojewoda; Malgorzata Schlegel-Zawadzka; Renata Wozniacka; Agnieszka Suder; Tomasz Kosciuk
Journal:  Am J Hum Biol       Date:  2003 May-Jun       Impact factor: 1.937

Review 3.  Risk factors of arm lymphedema in breast cancer patients.

Authors:  Z Kocak; J Overgaard
Journal:  Acta Oncol       Date:  2000       Impact factor: 4.089

Review 4.  Lymphedema: current issues in research and management.

Authors:  J A Petrek; P I Pressman; R A Smith
Journal:  CA Cancer J Clin       Date:  2000 Sep-Oct       Impact factor: 508.702

5.  Breast cancer-related lymphedema--what are the significant predictors and how they affect the severity of lymphedema?

Authors:  Atilla Soran; Gina D'Angelo; Mirsada Begovic; Figen Ardic; Ali Harlak; H Samuel Wieand; Victor G Vogel; Ronald R Johnson
Journal:  Breast J       Date:  2006 Nov-Dec       Impact factor: 2.431

6.  Arm lymphedema in patients treated conservatively for breast cancer: relationship to patient age and axillary node dissection technique.

Authors:  R D Pezner; M P Patterson; L R Hill; J A Lipsett; K R Desai; N Vora; J Y Wong; K H Luk
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-12       Impact factor: 7.038

7.  Lymphedema of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery.

Authors:  Thomas E Goffman; Christine Laronga; Lori Wilson; David Elkins
Journal:  Breast J       Date:  2004 Sep-Oct       Impact factor: 2.431

8.  Factors associated with increased breast cancer-related lymphedema volume.

Authors:  Stephane Vignes; Maria Arrault; Alain Dupuy
Journal:  Acta Oncol       Date:  2007       Impact factor: 4.089

9.  Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors.

Authors:  Sarah A McLaughlin; Mary J Wright; Katherine T Morris; Michelle R Sampson; Julia P Brockway; Karen E Hurley; Elyn R Riedel; Kimberly J Van Zee
Journal:  J Clin Oncol       Date:  2008-10-06       Impact factor: 44.544

10.  Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function.

Authors:  Sandra C Hayes; Monika Janda; Bruce Cornish; Diana Battistutta; Beth Newman
Journal:  J Clin Oncol       Date:  2008-07-20       Impact factor: 44.544

View more
  2 in total

Review 1.  Lymphedema: From diagnosis to treatment.

Authors:  Oğuz Kayıran; Carolyn De La Cruz; Kaori Tane; Atilla Soran
Journal:  Turk J Surg       Date:  2017-06-01

2.  Breast cancer-related lymphedema after axillary lymph node dissection: does early postoperative prediction model work?

Authors:  Atilla Soran; Ebru Menekse; Mark Girgis; Lori DeGore; Ronald Johnson
Journal:  Support Care Cancer       Date:  2015-09-09       Impact factor: 3.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.